Table 2.
Demographics among patients with elevated depression symptoms at baseline (and at least 2 PHQ-9 scores in the first 6 months)
| Demographics (N = 615) | N (%) |
|---|---|
| Gender | |
| Male | 211 (34.31) |
| Female | 404 (65.69) |
| Ethnicity | |
| Hispanic/Latino | 99 (16.10) |
| Not Hispanic/Latino | 458 (74.47) |
| Missing | 58 (9.43) |
| Race | |
| White/Caucasian | 354 (57.56) |
| Asian | 54 (8.78) |
| Black/African American | 35 (5.69) |
| Two or More Races | 19 (3.09) |
| Other/Unknowna | 153 (24.88) |
| Marital Status | |
| Married/Domestic Partner | 209 (33.98) |
| Previously Married/Domestic Partner | 40 (6.50) |
| Single | 348 (56.59) |
| Otherb | 18 (2.93) |
| Age | |
| Age at Baseline, Mean (SD) | 40.51 (14.82) |
| Baseline Depression Symptoms | |
| PHQ-9 Score, Mean (SD) | 15.87 (4.56) |
| Suicidal Ideation at Baseline | |
| Yesc | 248 (40.33) |
| Treatment Response by 6-month Follow-up | |
| PHQ-9 Score < 5 | 100 (16.26) |
| PHQ-9 Score < 10 | 289 (46.99) |
| Reduction in PHQ-9 Score ≥ 6 | 277 (45.04) |
| Other Clinical Symptoms at Baselined,e | |
| GAD-7 Score ≥ 10 | 434 (70.57) |
| AUDIT-C Score ≥ 3f | 228 (37.07) |
| DAST-10 Score ≥ 3g | 64 (10.41) |
| PCL Score > 50 | 174 (28.29) |
| Number of Treatment Sessions | |
| Total, Mean (SD)h | 7.29 (4.04) |
| With a Physician, Mean (SD) | 2.81 (2.02) |
| With a Therapist, Mean (SD) | 3.91 (4.33) |
a “Other/Unknown” includes: “American Indian or Alaska Native”, “Native Hawaiian or Other Pacific Islander”, “Other”, “Unknown”
b “Other” includes: Life Partner, Significant Other, Unknown, Other, Missing
c Includes any endorsement on PHQ-9 item 9 except “Not at all”
d Percentage is out of the total N = 615, though some patients had a missing value on the AUDIT-C, DAST-10, and/or PCL
e For the purposes of the analyses, patients who did not meet screening criteria for a given measure were given a “No” on meeting a clinical threshold (rather than given a missing status)
f Clinical cutoff is ≥3 for females, ≥ 4 for males
g Cutoff ≥3 indicates at least “moderate” symptoms; patients were only administered the DAST-10 if they screened positive on the 1-item screener
h Includes visits that did not indicate a provider type